Liguori, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 1.879
AS - Asia 1.658
EU - Europa 1.207
SA - Sud America 293
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.090
Nazione #
US - Stati Uniti d'America 1.823
SG - Singapore 764
CN - Cina 342
IT - Italia 253
BR - Brasile 242
DE - Germania 238
SE - Svezia 202
VN - Vietnam 186
FR - Francia 117
IE - Irlanda 82
GB - Regno Unito 75
FI - Finlandia 58
IN - India 54
ID - Indonesia 52
JP - Giappone 51
BD - Bangladesh 49
CA - Canada 35
HK - Hong Kong 35
RU - Federazione Russa 30
KR - Corea 26
AR - Argentina 21
BE - Belgio 21
AT - Austria 19
PL - Polonia 19
ZA - Sudafrica 19
ES - Italia 15
IQ - Iraq 15
TR - Turchia 15
CZ - Repubblica Ceca 14
NL - Olanda 14
UA - Ucraina 13
PK - Pakistan 11
CH - Svizzera 9
SA - Arabia Saudita 9
MX - Messico 8
CI - Costa d'Avorio 7
CL - Cile 7
EC - Ecuador 7
EG - Egitto 7
IR - Iran 7
JO - Giordania 7
DZ - Algeria 6
MA - Marocco 6
PH - Filippine 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
CO - Colombia 4
DK - Danimarca 4
LB - Libano 4
OM - Oman 4
BO - Bolivia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
PA - Panama 2
PY - Paraguay 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
EU - Europa 1
GR - Grecia 1
HT - Haiti 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 5.090
Città #
Singapore 436
San Jose 263
Ashburn 199
New York 156
Frankfurt am Main 148
Chandler 136
Beijing 85
Dublin 82
Rome 78
Hefei 77
Ho Chi Minh City 69
Dallas 63
Chicago 60
Los Angeles 52
Lauterbourg 49
Jakarta 48
Tokyo 48
Helsinki 42
The Dalles 42
Hanoi 35
Milan 34
Tukwila 32
Hong Kong 31
Munich 31
Seoul 26
Council Bluffs 24
Moscow 24
São Paulo 24
Kent 22
Brussels 21
Brooklyn 19
Santa Clara 18
Atlanta 17
Boston 17
Castelnuovo di Val di Cecina 17
Da Nang 14
Princeton 14
San Mateo 14
Denver 13
Boardman 12
London 12
Nuremberg 12
Brno 11
Buffalo 11
Johannesburg 11
Marseille 11
Palermo 11
Paris 11
Turku 11
Hyderabad 10
Poplar 10
Toronto 10
Warsaw 10
Wilmington 10
Bremen 9
Dhaka 9
Düsseldorf 9
Falls Church 9
Montreal 9
Houston 8
Rio de Janeiro 8
Seattle 8
Vienna 8
Zurich 8
Abidjan 7
Amman 7
Augusta 7
Baghdad 7
Manchester 7
North Bergen 7
Curitiba 6
Norwalk 6
Roubaix 6
Belo Horizonte 5
Bexley 5
Biên Hòa 5
Campinas 5
Chennai 5
Haiphong 5
Lappeenranta 5
Mumbai 5
Orem 5
Ottawa 5
Shanghai 5
Washington 5
Wroclaw 5
Calgary 4
Duque de Caxias 4
Falkenstein 4
Genoa 4
Guarulhos 4
Istanbul 4
Kish 4
Portland 4
Portsmouth 4
Pune 4
Riyadh 4
San Francisco 4
St Louis 4
Amsterdam 3
Totale 3.008
Nome #
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 264
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 185
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 168
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 167
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 153
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 149
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 135
The role of elastography in non-Alcoholic fatty liver disease 128
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 122
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 121
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 120
Acute HEV hepatitis: clinical and laboratory diagnosis 119
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 118
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 114
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 110
Clinical impact of comorbidities in an Italian NAFLD cohort 109
Reasons for Tooth Extractions and Related Risk Factors in Adult Patients: A Cohort Study 104
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 101
Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study 100
Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis 100
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 99
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 98
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 98
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 96
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 96
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 94
Increased serum ferritin levels predict long-term mortality in patients with NAFLD 93
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 93
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 92
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 91
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients 89
Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease 89
Nonalcoholic fatty liver disease (Nafld) as model of gut–liver axis interaction: From pathophysiology to potential target of treatment for personalized therapy 88
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 82
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 82
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease 79
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 77
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 77
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 76
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease 71
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients 69
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. a Longitudinal International Study 68
TACROLIMUS BLOOD-BILE RATIO FOR THE EARLY DETECTION OF THE REJECTION GRAFT INJURY AFTER LIVER TRANSPLANTATION 62
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 60
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. a Longitudinal International Study 50
Totale 5.174
Categoria #
all - tutte 24.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022148 5 1 5 19 15 9 3 27 8 4 26 26
2022/2023616 56 47 23 54 77 90 55 47 50 40 55 22
2023/2024565 45 143 26 35 26 81 51 17 8 40 28 65
2024/20251.048 20 5 90 37 78 42 28 53 129 123 234 209
2025/20262.710 348 64 195 340 354 310 429 135 207 153 135 40
Totale 5.174